Tag | Content |
---|
EnhancerAtlas ID | HS034-23027 |
Organism | Homo sapiens |
Tissue/cell | ECC-1 |
Coordinate | chr4:79481320-79482170 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
DUX4 | MA0468.1 | chr4:79481763-79481774 | TGATTAAATTA | - | 6.62 | FOSL1 | MA0477.1 | chr4:79481911-79481922 | CATGAGTCACC | - | 6.62 | FOSL2 | MA0478.1 | chr4:79481912-79481923 | ATGAGTCACCC | - | 6.14 | JUNB | MA0490.1 | chr4:79481912-79481923 | ATGAGTCACCC | - | 6.32 | JUND | MA0491.1 | chr4:79481911-79481922 | CATGAGTCACC | - | 6.02 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_34437 | chr4:79481066-79484432 | HCT-116 | SE_35890 | chr4:79476731-79483322 | HMEC | SE_64594 | chr4:79476354-79483167 | NHEK |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr4 | 79481343 | 79481590 | chr4 | 79481675 | 79482059 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH04I078555 | chr4 | 79476215 | 79483690 |
|
Enhancer Sequence | TTTCCACTCC TAGTGGGCAT ACTGGAATAC AGTTCTGACA CTAACTACCC AGCATTAGCA 60 TCAGATTCCA CAGGATTAAG GGTTCAGTCC TCTGCAAAAC TGCCCTCACT TCAGATGTCA 120 GTTCAAGTGT CGGGAATCAC CTGCACTTCT GGCCAACTGG CTATAAATTT AGGAGTTTTC 180 ATGACCCTCT GAAATTAAAG AATTCCCTAG AATGATTCAC AGAACTCACT GAAAGTGCTA 240 TCCTTATGAA TGCAAGTTTA TTATGAGGGA TACCCATGGG CAAGCTCTGG AAGGGTCCTG 300 GACCCAGAGC CTCCATGCCC TCTCCCTGTG GCATCAGGGC ACCTCACCCT CCTTTGTGTC 360 AGTGTGTTCA ATAACCAGGA AGCTCCTCTG AGCCTCAGTG TCCAGAATTG TAATTGGAGT 420 TCCATTATGT AGACACGAAT GATTGATTAA ATTATTTGTT ACATGATTGA ACTCAATATC 480 CAGCCCCTCT TTCCTCCTCA GAGGTCTGGC TGACCAGAGT TGCAACCCTG TGATCACAGG 540 GCTAATCTTT CTGGAGACCA GCCATCATTC TAAGGCTATC TAAGGGTCTA CCATGAGTCA 600 CCCCAATTGC ATCACAAAGT CACTCCTATC ACTCAGGAAA TTCCAAGGGT TTTTGAAGCT 660 CTATGCCAAG AACCAGTGCA AAGACCAGAT ACATTCCTAA TTATACTACA CATCTATAAC 720 TCACATTAAG GCACACAGTT TCCAATATAT ATTCTTTTAT TTTTGACTAA CATTATATTA 780 AAAATAAATA AAGTTATATT AATACCAATG GCCCTGGCTA TTTATGTTGA TCAGAAGCTC 840 TGATTTTTAG 850
|